I am a bit surprised about the increments in dosing. It started with 2.5, 7.5 and 20mg and is now at once increased to 60mg. That is 3 times the highest dose during the previous trials and 24 times the lowest dose of those trials. Was so little known about safety limits before? Otherwise they wouldn't have been so conservative in their previous dosing, I guess?
This implies that we may not see "robust" efficacy data until after we get interim or full results from the 60mg dosing. Of course, I'm happy about safety, but we need the obvious efficacy.